Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3552 entries
Sorted by: Best Match Show Resources per page
A Systematic Review of Research Guidelines in Decision-Analytic Modeling.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Ramos MC, Barton P, Jowett S, Sutton AJ.
PMID: 26091606
Value Health. 2015 Jun;18(4):512-29. doi: 10.1016/j.jval.2014.12.014. Epub 2015 Feb 07.

BACKGROUND: Decision-analytic modeling (DAM) has been increasingly used to aid decision making in health care. The growing use of modeling in economic evaluations has led to increased scrutiny of the methods used.OBJECTIVE: The objective of this study was to...

Cite
Ramos MC, Barton P, Jowett S, et al. A Systematic Review of Research Guidelines in Decision-Analytic Modeling. Value Health. 2015;18(4):512-29doi: 10.1016/j.jval.2014.12.014.
Ramos, M. C., Barton, P., Jowett, S., & Sutton, A. J. (2015). A Systematic Review of Research Guidelines in Decision-Analytic Modeling. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 18(4), 512-29. https://doi.org/10.1016/j.jval.2014.12.014
Ramos, Maria Cristina Peñaloza, et al. "A Systematic Review of Research Guidelines in Decision-Analytic Modeling." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 18,4 (2015): 512-29. doi: https://doi.org/10.1016/j.jval.2014.12.014
Ramos MC, Barton P, Jowett S, Sutton AJ. A Systematic Review of Research Guidelines in Decision-Analytic Modeling. Value Health. 2015 Jun;18(4):512-29. doi: 10.1016/j.jval.2014.12.014. Epub 2015 Feb 07. PMID: 26091606.
Copy Download .nbib Format: NLM
Advancing High-Quality Value Assessments of Health Care Interventions.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Doshi JA, Willke RJ.
PMID: 28237192
Value Health. 2017 Feb;20(2):181-184. doi: 10.1016/j.jval.2016.12.012. Epub 2017 Jan 27.

No abstract available.

Cite
Doshi JA, Willke RJ. Advancing High-Quality Value Assessments of Health Care Interventions. Value Health. 2017;20(2):181-184doi: 10.1016/j.jval.2016.12.012.
Doshi, J. A., & Willke, R. J. (2017). Advancing High-Quality Value Assessments of Health Care Interventions. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(2), 181-184. https://doi.org/10.1016/j.jval.2016.12.012
Doshi, Jalpa A, and Willke, Richard J. "Advancing High-Quality Value Assessments of Health Care Interventions." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 20,2 (2017): 181-184. doi: https://doi.org/10.1016/j.jval.2016.12.012
Doshi JA, Willke RJ. Advancing High-Quality Value Assessments of Health Care Interventions. Value Health. 2017 Feb;20(2):181-184. doi: 10.1016/j.jval.2016.12.012. Epub 2017 Jan 27. PMID: 28237192.
Copy Download .nbib Format: NLM
Predicting the Impact of Value-Based Assessment on Future Nice Appraisals.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Beale RC, Maruszczak M, Kusel J.
PMID: 27200569
Value Health. 2014 Nov;17(7):A330. doi: 10.1016/j.jval.2014.08.611. Epub 2014 Oct 26.

No abstract available.

Cite
Beale RC, Maruszczak M, Kusel J. Predicting the Impact of Value-Based Assessment on Future Nice Appraisals. Value Health. 2014;17(7):A330doi: 10.1016/j.jval.2014.08.611.
Beale, R. C., Maruszczak, M., & Kusel, J. (2014). Predicting the Impact of Value-Based Assessment on Future Nice Appraisals. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A330. https://doi.org/10.1016/j.jval.2014.08.611
Beale, R C, et al. "Predicting the Impact of Value-Based Assessment on Future Nice Appraisals." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A330. doi: https://doi.org/10.1016/j.jval.2014.08.611
Beale RC, Maruszczak M, Kusel J. Predicting the Impact of Value-Based Assessment on Future Nice Appraisals. Value Health. 2014 Nov;17(7):A330. doi: 10.1016/j.jval.2014.08.611. Epub 2014 Oct 26. PMID: 27200569.
Copy Download .nbib Format: NLM
Regional Assessment of Severe Hypoglycemic Coma Events in Finland.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Vattulainen P, Mushnikov V, Hoti F, Saukkonen T, Korhonen P.
PMID: 27200578
Value Health. 2014 Nov;17(7):A332. doi: 10.1016/j.jval.2014.08.627. Epub 2014 Oct 26.

No abstract available.

Cite
Vattulainen P, Mushnikov V, Hoti F, et al. Regional Assessment of Severe Hypoglycemic Coma Events in Finland. Value Health. 2014;17(7):A332doi: 10.1016/j.jval.2014.08.627.
Vattulainen, P., Mushnikov, V., Hoti, F., Saukkonen, T., & Korhonen, P. (2014). Regional Assessment of Severe Hypoglycemic Coma Events in Finland. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A332. https://doi.org/10.1016/j.jval.2014.08.627
Vattulainen, P, et al. "Regional Assessment of Severe Hypoglycemic Coma Events in Finland." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A332. doi: https://doi.org/10.1016/j.jval.2014.08.627
Vattulainen P, Mushnikov V, Hoti F, Saukkonen T, Korhonen P. Regional Assessment of Severe Hypoglycemic Coma Events in Finland. Value Health. 2014 Nov;17(7):A332. doi: 10.1016/j.jval.2014.08.627. Epub 2014 Oct 26. PMID: 27200578.
Copy Download .nbib Format: NLM
Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Thorlund K, Siliman G, Eapen S, Lund S, Palencia R.
PMID: 27200580
Value Health. 2014 Nov;17(7):A332-3. doi: 10.1016/j.jval.2014.08.629. Epub 2014 Oct 26.

No abstract available.

Cite
Thorlund K, Siliman G, Eapen S, et al. Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin. Value Health. 2014;17(7):A332-3doi: 10.1016/j.jval.2014.08.629.
Thorlund, K., Siliman, G., Eapen, S., Lund, S., & Palencia, R. (2014). Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A332-3. https://doi.org/10.1016/j.jval.2014.08.629
Thorlund, K, et al. "Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A332-3. doi: https://doi.org/10.1016/j.jval.2014.08.629
Thorlund K, Siliman G, Eapen S, Lund S, Palencia R. Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin. Value Health. 2014 Nov;17(7):A332-3. doi: 10.1016/j.jval.2014.08.629. Epub 2014 Oct 26. PMID: 27200580.
Copy Download .nbib Format: NLM
Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Hawkins N, Scott DA.
PMID: 27200589
Value Health. 2014 Nov;17(7):A334. doi: 10.1016/j.jval.2014.08.638. Epub 2014 Oct 26.

No abstract available.

Cite
Hawkins N, Scott DA. Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes. Value Health. 2014;17(7):A334doi: 10.1016/j.jval.2014.08.638.
Hawkins, N., & Scott, D. A. (2014). Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A334. https://doi.org/10.1016/j.jval.2014.08.638
Hawkins, N, and Scott, D A. "Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A334. doi: https://doi.org/10.1016/j.jval.2014.08.638
Hawkins N, Scott DA. Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes. Value Health. 2014 Nov;17(7):A334. doi: 10.1016/j.jval.2014.08.638. Epub 2014 Oct 26. PMID: 27200589.
Copy Download .nbib Format: NLM
The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Diels J, Angermund R, Schroeder M, Worbes-Cerezo M, Thompson G.
PMID: 27200590
Value Health. 2014 Nov;17(7):A334. doi: 10.1016/j.jval.2014.08.639. Epub 2014 Oct 26.

No abstract available.

Cite
Diels J, Angermund R, Schroeder M, et al. The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM). Value Health. 2014;17(7):A334doi: 10.1016/j.jval.2014.08.639.
Diels, J., Angermund, R., Schroeder, M., Worbes-Cerezo, M., & Thompson, G. (2014). The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A334. https://doi.org/10.1016/j.jval.2014.08.639
Diels, J, et al. "The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A334. doi: https://doi.org/10.1016/j.jval.2014.08.639
Diels J, Angermund R, Schroeder M, Worbes-Cerezo M, Thompson G. The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM). Value Health. 2014 Nov;17(7):A334. doi: 10.1016/j.jval.2014.08.639. Epub 2014 Oct 26. PMID: 27200590.
Copy Download .nbib Format: NLM
Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Hawkins N, Padhiar A, Thompson J, Scott DA, Eaton JN, Varol N, Norrbacka K, Boye KS, Nicolay C.
PMID: 27200592
Value Health. 2014 Nov;17(7):A335. doi: 10.1016/j.jval.2014.08.641. Epub 2014 Oct 26.

No abstract available.

Cite
Hawkins N, Padhiar A, Thompson J, et al. Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes. Value Health. 2014;17(7):A335doi: 10.1016/j.jval.2014.08.641.
Hawkins, N., Padhiar, A., Thompson, J., Scott, D. A., Eaton, J. N., Varol, N., Norrbacka, K., Boye, K. S., & Nicolay, C. (2014). Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A335. https://doi.org/10.1016/j.jval.2014.08.641
Hawkins, N, et al. "Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A335. doi: https://doi.org/10.1016/j.jval.2014.08.641
Hawkins N, Padhiar A, Thompson J, Scott DA, Eaton JN, Varol N, Norrbacka K, Boye KS, Nicolay C. Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes. Value Health. 2014 Nov;17(7):A335. doi: 10.1016/j.jval.2014.08.641. Epub 2014 Oct 26. PMID: 27200592.
Copy Download .nbib Format: NLM
Recombinant Growth Hormone Therapy in Children with GH Deficiency: First Interventional Study in Armenia.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Markosyan R, Perikhanyan A.
PMID: 27200601
Value Health. 2014 Nov;17(7):A336. doi: 10.1016/j.jval.2014.08.646. Epub 2014 Oct 26.

No abstract available.

Cite
Markosyan R, Perikhanyan A. Recombinant Growth Hormone Therapy in Children with GH Deficiency: First Interventional Study in Armenia. Value Health. 2014;17(7):A336doi: 10.1016/j.jval.2014.08.646.
Markosyan, R., & Perikhanyan, A. (2014). Recombinant Growth Hormone Therapy in Children with GH Deficiency: First Interventional Study in Armenia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A336. https://doi.org/10.1016/j.jval.2014.08.646
Markosyan, R, and Perikhanyan, A. "Recombinant Growth Hormone Therapy in Children with GH Deficiency: First Interventional Study in Armenia." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A336. doi: https://doi.org/10.1016/j.jval.2014.08.646
Markosyan R, Perikhanyan A. Recombinant Growth Hormone Therapy in Children with GH Deficiency: First Interventional Study in Armenia. Value Health. 2014 Nov;17(7):A336. doi: 10.1016/j.jval.2014.08.646. Epub 2014 Oct 26. PMID: 27200601.
Copy Download .nbib Format: NLM
Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle: A Systematic Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Sun L, Sun J, Chen B, Sun S, Wang R, Ren X.
PMID: 27200602
Value Health. 2014 Nov;17(7):A336. doi: 10.1016/j.jval.2014.08.647. Epub 2014 Oct 26.

No abstract available.

Cite
Sun L, Sun J, Chen B, et al. Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle: A Systematic Review. Value Health. 2014;17(7):A336doi: 10.1016/j.jval.2014.08.647.
Sun, L., Sun, J., Chen, B., Sun, S., Wang, R., & Ren, X. (2014). Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle: A Systematic Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A336. https://doi.org/10.1016/j.jval.2014.08.647
Sun, L, et al. "Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle: A Systematic Review." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A336. doi: https://doi.org/10.1016/j.jval.2014.08.647
Sun L, Sun J, Chen B, Sun S, Wang R, Ren X. Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle: A Systematic Review. Value Health. 2014 Nov;17(7):A336. doi: 10.1016/j.jval.2014.08.647. Epub 2014 Oct 26. PMID: 27200602.
Copy Download .nbib Format: NLM
Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Sánchez-Piedra C, García-Pérez S, Sarría-Santamera A.
PMID: 27200615
Value Health. 2014 Nov;17(7):A339. doi: 10.1016/j.jval.2014.08.666. Epub 2014 Oct 26.

No abstract available.

Cite
Sánchez-Piedra C, García-Pérez S, Sarría-Santamera A. Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model. Value Health. 2014;17(7):A339doi: 10.1016/j.jval.2014.08.666.
Sánchez-Piedra, C., García-Pérez, S., & Sarría-Santamera, A. (2014). Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A339. https://doi.org/10.1016/j.jval.2014.08.666
Sánchez-Piedra, C, et al. "Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A339. doi: https://doi.org/10.1016/j.jval.2014.08.666
Sánchez-Piedra C, García-Pérez S, Sarría-Santamera A. Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model. Value Health. 2014 Nov;17(7):A339. doi: 10.1016/j.jval.2014.08.666. Epub 2014 Oct 26. PMID: 27200615.
Copy Download .nbib Format: NLM
Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

García-Pérez S, Sánchez-Piedra C, Sarría-Santamera A.
PMID: 27200616
Value Health. 2014 Nov;17(7):A339. doi: 10.1016/j.jval.2014.08.667. Epub 2014 Oct 26.

No abstract available.

Cite
García-Pérez S, Sánchez-Piedra C, Sarría-Santamera A. Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model. Value Health. 2014;17(7):A339doi: 10.1016/j.jval.2014.08.667.
García-Pérez, S., Sánchez-Piedra, C., & Sarría-Santamera, A. (2014). Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A339. https://doi.org/10.1016/j.jval.2014.08.667
García-Pérez, S, et al. "Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A339. doi: https://doi.org/10.1016/j.jval.2014.08.667
García-Pérez S, Sánchez-Piedra C, Sarría-Santamera A. Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model. Value Health. 2014 Nov;17(7):A339. doi: 10.1016/j.jval.2014.08.667. Epub 2014 Oct 26. PMID: 27200616.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3552 entries